Patrick Forde @patrickforde.bsky.social · 09/01/2025Now in @JCO_ASCO led by @DrMarkAwad & @MARIANOPROVENCI exploratory arm neoadj ipi nivo for resectable lung cancer in #CM816 w lots of interesting data! Combo neoadj PD1-CTLA4 blockade without chemo likely not a viable strategy for all comers in NSCLC #lcsm ascopubs.org/doi/10.1200/JC… 070
Patrick Forde @patrickforde.bsky.social · 21/11/2024Excellent presentation by Dr. @VirginiaCalvo6 @gecp_org of the recently published Spanish Lung Cancer Group consensus on management of stage III NSCLC. Neoadjuvant chemo-IO has changed the game for this stage of disease. #lcsm 1100
Patrick Forde @patrickforde.bsky.social · 18/11/2024Anyone come across this before? It seems this trial recruitment company cold emails oncologists and offers them cash to refer pts to other centers for specific clinical trials, seems ethically v murky and perhaps legally so as well? 121